Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (869)
Edwards Lifesciences Corp (EW)
BOBO DONALD E JR — CVP,Strategy/Corp Development
Shares
4,676
Price
$80.59
Total Value
$376.85K
Shares Held After
39,270
% of Holdings
10.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,200
Price
$64.89
Total Value
$272.53K
Shares Held After
767,780
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,800
Price
$64.06
Total Value
$1.01M
Shares Held After
771,980
% of Holdings
2.0%
Lipocine Inc. (LPCN)
Patel Mahesh V. — Director
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%
Precipio, Inc. (PRPO)
Sabet Ahmed Zaki — Chief Operating Officer
Shares
19
Price
$27.93
Total Value
$530.67
Shares Held After
1,034
% of Holdings
1.8%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
30,078
Price
$24.58
Total Value
$739.32K
Shares Held After
1,047,205
% of Holdings
2.8%
Beam Therapeutics Inc. (BEAM)
Simon Amy — Chief Medical Officer
Shares
6,700
Price
$24.58
Total Value
$164.69K
Shares Held After
102,735
% of Holdings
6.1%
Beam Therapeutics Inc. (BEAM)
Ciaramella Giuseppe — President
Shares
11,810
Price
$24.58
Total Value
$290.29K
Shares Held After
218,406
% of Holdings
5.1%
Beam Therapeutics Inc. (BEAM)
Cavanagh Bethany J — SVP, Finance and Treasurer
Shares
3,242
Price
$24.58
Total Value
$79.69K
Shares Held After
51,171
% of Holdings
6.0%
Beam Therapeutics Inc. (BEAM)
Bellon Christine — Chief Legal Officer
Shares
5,956
Price
$24.58
Total Value
$146.40K
Shares Held After
109,711
% of Holdings
5.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,300
Price
$49.98
Total Value
$64.97K
Shares Held After
97,994
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
6,200
Price
$49.21
Total Value
$305.10K
Shares Held After
99,294
% of Holdings
5.9%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
7,958
Price
$50.00
Total Value
$397.90K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
2,656
Price
$49.92
Total Value
$132.59K
Shares Held After
627,540
% of Holdings
0.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
12,344
Price
$49.20
Total Value
$607.32K
Shares Held After
630,196
% of Holdings
1.9%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
952
Price
$203.31
Total Value
$193.55K
Shares Held After
147,882
% of Holdings
0.6%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,000
Price
$202.36
Total Value
$202.36K
Shares Held After
148,834
% of Holdings
0.7%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
1,048
Price
$201.32
Total Value
$210.98K
Shares Held After
149,834
% of Holdings
0.7%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,909
Price
$205.00
Total Value
$391.35K
Shares Held After
224,885
% of Holdings
0.8%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,200
Price
$203.83
Total Value
$244.59K
Shares Held After
226,794
% of Holdings
0.5%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
3,213
Price
$203.07
Total Value
$652.47K
Shares Held After
227,994
% of Holdings
1.4%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,778
Price
$202.01
Total Value
$359.17K
Shares Held After
231,207
% of Holdings
0.8%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
300
Price
$200.79
Total Value
$60.24K
Shares Held After
232,985
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
100
Price
$85.89
Total Value
$8.59K
Shares Held After
208,398
% of Holdings
0.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,702
Price
$85.33
Total Value
$230.56K
Shares Held After
208,498
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,698
Price
$84.31
Total Value
$227.47K
Shares Held After
211,200
% of Holdings
1.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,100
Price
$85.46
Total Value
$94.01K
Shares Held After
177,371
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
900
Price
$84.46
Total Value
$76.01K
Shares Held After
178,471
% of Holdings
0.5%
Twist Bioscience Corp (TWST)
Starovasnik Melissa A. — Director
Shares
1,000
Price
$51.00
Total Value
$51.00K
Shares Held After
25,722
% of Holdings
3.7%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
40
Price
$779.71
Total Value
$31.19K
Shares Held After
17,603
% of Holdings
0.2%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
4
Price
$778.24
Total Value
$3.11K
Shares Held After
17,643
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
9
Price
$777.42
Total Value
$7.00K
Shares Held After
17,647
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
13
Price
$776.62
Total Value
$10.10K
Shares Held After
17,656
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
14
Price
$775.58
Total Value
$10.86K
Shares Held After
17,669
% of Holdings
0.1%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$774.58
Total Value
$6.20K
Shares Held After
17,683
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
8
Price
$773.59
Total Value
$6.19K
Shares Held After
17,691
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
3
Price
$772.76
Total Value
$2.32K
Shares Held After
17,699
% of Holdings
0.0%
REGENERON PHARMACEUTICALS, INC. (REGN)
RYAN ARTHUR F — Director
Shares
1
Price
$771.32
Total Value
$771.32
Shares Held After
17,702
% of Holdings
0.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Gibson James R II — Chief Financial Officer
Shares
88,185
Price
$1.37
Total Value
$120.81K
Shares Held After
1,245,663
% of Holdings
6.6%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
8,820
Price
$17.81
Total Value
$157.08K
Shares Held After
0
% of Holdings
100.0%
Emergent BioSolutions Inc. (EBS)
Williams Paul Anthony — SVP, Products Business
Shares
4,000
Price
$8.44
Total Value
$33.76K
Shares Held After
62,681
% of Holdings
6.0%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
838
Price
$58.93
Total Value
$49.39K
Shares Held After
162,994
% of Holdings
0.5%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,412
Price
$58.14
Total Value
$82.09K
Shares Held After
165,406
% of Holdings
0.8%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
62,344
Price
$164.95
Total Value
$10.28M
Shares Held After
106,810
% of Holdings
36.9%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
19,001
Price
$164.11
Total Value
$3.12M
Shares Held After
169,154
% of Holdings
10.1%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
6,715
Price
$163.18
Total Value
$1.10M
Shares Held After
188,155
% of Holdings
3.4%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
5,727
Price
$18.64
Total Value
$106.75K
Shares Held After
125,373
% of Holdings
4.4%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,838
Price
$32.66
Total Value
$60.03K
Shares Held After
38,864
% of Holdings
4.5%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
80
Price
$70.30
Total Value
$5.62K
Shares Held After
60,137
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
12,530
Price
$69.50
Total Value
$870.84K
Shares Held After
60,217
% of Holdings
17.2%
Showing 301–350 of 869 transactions (page 7 of 18)